Octyl-α-ketoglutarate: Precision Tool for Prolyl Hydroxylase
2026-07-23
Octyl-α-ketoglutarate empowers researchers to dissect the hypoxia signaling pathway and restore prolyl hydroxylase activity in metabolically compromised cells. Its superior cell permeability and stability enable robust modeling of TCA cycle dysfunction and HIF-1α regulation for advanced cancer metabolism studies.
Exogenous NADH Potentiates Antibiotic Efficacy in E. tarda M
2026-07-22
This study demonstrates that exogenous NADH reprograms the metabolism of multidrug-resistant Edwardsiella tarda, enhancing the bactericidal effect of aminoglycoside antibiotics such as neomycin. The findings suggest a promising metabolic modulation strategy to combat antibiotic resistance in both aquaculture and clinical settings.
Cell Tumbling in 3D Hydrogels Drives Stem Cell Differentiati
2026-07-22
The referenced study uncovers a novel, rapid whole-cell movement—cell tumbling—in 3D hydrogels, showing it enhances stem cell differentiation by nuclear mechanotransduction. This mechanistic insight reshapes understanding of how physical cell behaviors in engineered niches regulate lineage commitment, with broad implications for tissue engineering and regenerative medicine.
Ertugliflozin (PF-04971729): Selectivity, Mechanistic Insigh
2026-07-21
Explore the advanced selectivity and multifaceted mechanisms of Ertugliflozin (PF-04971729) in diabetes mellitus research. This article uniquely bridges molecular pharmacology with translational assay strategy, providing new perspectives beyond existing coverage.
Tetracycline Hydrochloride: Mechanism and Antimicrobial Benc
2026-07-21
Tetracycline Hydrochloride, a bacteriostatic antibiotic, inhibits bacterial protein synthesis via 16S rRNA binding. It demonstrates proven efficacy against Staphylococcus aureus and Propionibacterium acnes, with well-characterized solubility and storage parameters.
Nuclear Export Inhibition for TNBC: Insights from KPT-330 St
2026-07-20
This study systematically identified synergistic drug combinations for triple-negative breast cancer (TNBC) using high-throughput screening, highlighting KPT-330 (Selinexor) as a potent XPO1 inhibitor. Combined with a PI3K/mTOR inhibitor, KPT-330 significantly reduced tumor burden in preclinical TNBC models, supporting CRM1/XPO1 inhibition as a promising therapeutic avenue.
NF 340: Innovative P2Y11 Antagonist for Assay Precision
2026-07-20
Explore how the P2Y11 antagonist NF 340 empowers immunology research and inflammation pathway modulation, with deep insights into assay design and translational impact. Discover unique guidance not found in existing NF 340 content.
MHY1485 (SKU B5853): Reliable mTOR Activation for Autophagy
2026-07-19
This article provides a scenario-driven, evidence-based exploration of MHY1485 (SKU B5853) as a potent mTOR activator for cellular assays. Addressing common laboratory challenges in autophagy and cell proliferation studies, it highlights how MHY1485 from APExBIO delivers consistent, data-backed results for advanced research workflows.
Homoharringtonine in Translational Oncology and Antiviral Re
2026-07-18
Explore the unique dual-domain impact of Homoharringtonine, a potent cytotoxic alkaloid, as both a cancer biology tool and a leading candidate for broad-spectrum antiviral research. This article offers deeper mechanistic insights and practical assay guidance beyond existing resources.
Cardiovascular Outcomes of Ertugliflozin in Type 2 Diabetes:
2026-07-17
The VERTIS CV trial rigorously assessed the cardiovascular safety of Ertugliflozin (PF-04971729), a selective SGLT2 inhibitor, in patients with type 2 diabetes and established atherosclerotic cardiovascular disease. The study found that Ertugliflozin was noninferior to placebo for major adverse cardiovascular events, providing critical evidence for its safety profile in this high-risk population.
Anagliptin (SK-0403): Advanced Workflows for Vascular and Di
2026-07-17
Anagliptin (SK-0403) empowers researchers to dissect both DPP-4 inhibition and direct vasorelaxant mechanisms, uniquely bridging metabolic and cardiovascular workflows. Harness recent mechanistic breakthroughs and actionable protocol enhancements to maximize reproducibility and translational insight in diabetes and vascular smooth muscle assays.
Transmission and Genetics of Carbapenemase in CREC, Guangdon
2026-07-16
Chen et al. (2025) provide a comprehensive molecular epidemiology of carbapenem-resistant Enterobacter cloacae (CREC) in eight hospitals across Guangdong, revealing high prevalence and efficient transmission of carbapenemase-encoding genes, particularly blaNDM-1. The study's robust genotyping and plasmid analysis inform future strategies in antimicrobial resistance research and surveillance.
Sitagliptin Phosphate Monohydrate: DPP-4 Inhibitor in Metabo
2026-07-16
Sitagliptin phosphate monohydrate empowers metabolic and diabetes researchers to dissect DPP-4-dependent incretin pathways with precision. This article translates cutting-edge reference findings into practical workflows, addressing experimental design, protocol optimization, and troubleshooting for robust, reproducible results.
Elobixibat Hydrate: Protocols & Precision for IBAT Inhibitio
2026-07-15
Elobixibat hydrate is redefining the research landscape for ileal bile acid transporter inhibition, offering unmatched selectivity and translational power in chronic idiopathic constipation and metabolic studies. This guide details experimental workflows, troubleshooting, and advanced applications, ensuring researchers achieve robust and reproducible results with APExBIO’s high-purity compound.
JHU-083: Advancing Glutaminase Pathway Research in Disease M
2026-07-15
JHU-083, a next-generation 6-diazo-5-oxo-L-norleucine precursor, empowers researchers to dissect glutaminase-driven mechanisms in neurological and inflammatory models with unprecedented selectivity and workflow flexibility. Its high solubility, purity, and targeted inhibition profile make it a decisive tool for studies demanding precise manipulation of glutamate metabolism.
460 records 11/31 page Previous Next First page 上5页 1112131415 下5页 Last page